13.44MMarket Cap-466P/E (TTM)
1.2896High1.2400Low36.41KVolume1.2800Open1.2650Pre Close45.83KTurnover0.46%Turnover RatioLossP/E (Static)10.75MShares7.333052wk High-0.73P/B9.87MFloat Cap1.100052wk Low--Dividend TTM7.90MShs Float769.9000Historical High--Div YieldTTM3.92%Amplitude1.1000Historical Low1.2580Avg Price1Lot Size
NRX Pharmaceuticals Stock Forum
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric Clinic | NRXP Stock News
11 MINUTES AGO, 7:00 AM EDT
VIA PR NEWSWIRE
• Stability milestone supports submission of FDA New Drug Application by NRx for the use of intravenous ketamine to treat Suicidal Depression
• Ketamine is currently used off-label for this indication. However, FDA approval is typically required for patient...
HOPE Therapeutics Secures Financing For Ketamine Clinic Expansion
HOPE Therapeutics, Inc., a subsidiary of
https://www.moomoo.com/t/news/post/42897644/mbyzFRmrUf
Benzinga· 1 min ago
No comment yet